EUVIMEDEUVIMED entdecken
Crossref

Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity

Zhussipbek Mukhatayev, Artur Kovenskiy, Ziyou Ren, Stephanie M Rangel, Nurlubek Katkenov, Yerkhanat Khuanbai, Rohan Shivde, Moriel Daniel, Emilia R Dellacecca, Kettil Cedercreutz, Yekaterina Ostapchuk, Ayaulum Nurgozhina und 15 weitere

Journal of Investigative Dermatology · 2025

DOI: 10.1016/j.jid.2025.01.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025. Verfasst von Zhussipbek Mukhatayev und 26 weiteren Autor:innen. Beteiligte Einrichtung: National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Electronic address: zhussipbek.mukhatayev@childrens.harvard.edu. Hauptthemen laut MEDLINE: Vitiligo, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: LEO Fondet, Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania, Ministry of Education and Science of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a cutaneous autoimmune disorder characterized by progressive depigmentation due to melanocyte destruction by cytotoxic T cells. Genetic factors predispose patients to the disease and are supported by environmental factors that often initiate new disease episodes. We investigated whether disease outcomes were partially defined by pathogenic microbes that drive nutrient deficiency and inflammation. Our study presents the results of research on the diet and gut microbiome composition of patients with vitiligo and healthy controls from Kazakhstan and the United States. Dietary nutrient intake was assessed using the National Institutes of Health-generated Diet History Questionnaire. Patients with active vitiligo exhibit a limited intake of specific fatty acids, amino acids, fiber, and zinc. Disease activity was further characterized by the abundance of Odoribacter and Escherichia in the gut. Metabolic pathway analysis supported the role of the Escherichia genus in disease activity by limiting energy metabolism and amino acid biosynthetic pathways. Disease activity also aligned with elevated circulating pro-inflammatory cytokines. These findings suggest that nutritional limitations are not compensated by metabolites from the gut microbiome in active disease, potentially leaving room for inflammation and exacerbating vitiligo. The intricate relationship among diet, gut microbiome composition, and disease progression in vitiligo highlights potential avenues for targeted interventions to reduce autoimmune activity and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoGastrointestinal MicrobiomeHumansFemaleMaleAdultMiddle AgedDietEnergy MetabolismDisease ProgressionCase-Control StudiesYoung Adult

Stichwörter der Autor:innen

AutoimmunityImmunologyMicrobiomeVitiligo

Autor:innen und Institutionen

  • National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Electronic address: zhussipbek.mukhatayev@childrens.harvard.edu.
  • National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan.
  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Temprian Therapeutics, Chicago, Illinois, USA.
  • Almaty Branch of the National Center for Biotechnology, Almaty, Kazakhstan.
  • Genomics and Microbiome Core Facility, Rush University, Chicago, Illinois, USA.

Förderung

  • LEO Fondet
  • Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania
  • Ministry of Education and Science of the Republic of Kazakhstan

Zitieren

APA

Mukhatayev, Z., Kovenskiy, A., Ren, Z., Rangel, S. M., Katkenov, N., Khuanbai, Y., Shivde, R., Daniel, M., Dellacecca, E. R., Cedercreutz, K., Ostapchuk, Y., Nurgozhina, A., Chulenbayeva, L., Nurgaziyev, M., Jarmukhanov, Z., Nurlankyzy, M., Kozhdan, K., Seidulla, S., Mukhanbetzhanova, Z., …, & Le Poole, I. C. (2025). Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2025.01.032

Vancouver

Mukhatayev Z, Kovenskiy A, Ren Z, Rangel SM, Katkenov N, Khuanbai Y, et al. Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity. Journal of Investigative Dermatology. 2025. doi:10.1016/j.jid.2025.01.032

BibTeX
@article{Mukhatayev2025,
  author = {Mukhatayev, Zhussipbek and Kovenskiy, Artur and Ren, Ziyou and Rangel, Stephanie M and Katkenov, Nurlubek and Khuanbai, Yerkhanat and Shivde, Rohan and Daniel, Moriel and Dellacecca, Emilia R and Cedercreutz, Kettil and Ostapchuk, Yekaterina and Nurgozhina, Ayaulum and Chulenbayeva, Laura and Nurgaziyev, Madiyar and Jarmukhanov, Zharkyn and Nurlankyzy, Marzhan and Kozhdan, Kamilya and Seidulla, Symbat and Mukhanbetzhanova, Zhanel and Sergazy, Shynggyss and Kozhakhmetov, Samat and Ali, Yasmeen and Daftary, Karishma M and Green, Stefan J and Kundu, Roopal V and Kushugulova, Almagul and Le Poole, I Caroline},
  title = {Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  doi = {10.1016/j.jid.2025.01.032}
}
Kostenlos starten →